Last 12 months
Inside the activity.
4 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2021 Filed Feb 24, 2021 01:39 UTC |
Hoffman Alan LEVP, Global Corporate Affairs
|
Tax withholdingCommon Stock | 655 | $48.33 | $31,656.15 |
DisclosureSEC source: 0001209191-21-013533 · doc4.xml · nonDerivative · entry 2 Hoffman Alan L · CIK 0001624527 · EVP, Global Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,178 F2 · shares: Units withheld to satisfy tax withholding obligations due in connection with the vesting of RSUs previously granted to the Reporting Person on February 20, 2020. Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 01:36 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Tax withholdingCommon Stock | 786 | $48.33 | $37,987.38 |
DisclosureSEC source: 0001209191-21-013529 · doc4.xml · nonDerivative · entry 2 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,916 F2 · shares: Units withheld to satisfy tax withholding obligations due in connection with the vesting of RSUs previously granted to the Reporting Person on February 20, 2020. Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 01:35 UTC |
DeSimone JohnPresident
|
Tax withholdingCommon Stock | 838 | $48.33 | $40,500.54 |
DisclosureSEC source: 0001209191-21-013527 · doc4.xml · nonDerivative · entry 2 DeSimone John · CIK 0001463405 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,418 F2 · shares: Units withheld to satisfy tax withholding obligations due in connection with the vesting of RSUs previously granted to the Reporting Person on February 20, 2020. Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 01:34 UTC |
Agwunobi John ODirector · Chairman and CEO
|
Tax withholdingCommon Stock | 838 | $48.33 | $40,500.54 |
DisclosureSEC source: 0001209191-21-013526 · doc4.xml · nonDerivative · entry 2 Agwunobi John O · CIK 0001627893 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,149 F2 · shares: Units withheld to satisfy tax withholding obligations due in connection with the vesting of RSUs previously granted to the Reporting Person on February 20, 2020. Read SEC document |
| February 19, 2021 Filed Feb 24, 2021 01:45 UTC |
Irani Jehangir DSVP, PAO
|
GrantCommon Stock | 4,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013544 · doc4.xml · nonDerivative · entry 1 Irani Jehangir D · CIK 0001775818 · SVP, PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,970 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 20% on February 19, 2022, 20% on February 19, 2023, and 60% on February 19, 2024, subject to continued service through each vesting date. Read SEC document |
| February 19, 2021 Filed Feb 24, 2021 01:44 UTC |
Hienrich EdiSVP/Managing Director EMEA
|
GrantCommon Stock | 4,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013541 · doc4.xml · nonDerivative · entry 4 Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 18,577 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 20% on February 19, 2022, 20% on February 19, 2023, and 60% on February 19, 2024, subject to continued service through each vesting date. Read SEC document |
| February 19, 2021 Filed Feb 24, 2021 01:44 UTC |
Hienrich EdiSVP/Managing Director EMEA
|
GrantCommon Stock | 10,345 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013541 · doc4.xml · nonDerivative · entry 1 Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,633 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 20% on February 19, 2022, 20% on February 19, 2023, and 60% on February 19, 2024, subject to continued service through each vesting date. Read SEC document |
| February 19, 2021 Filed Feb 24, 2021 01:42 UTC |
Harms ThomasSVP, China & APAC
|
GrantCommon Stock | 10,345 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013539 · doc4.xml · nonDerivative · entry 1 Harms Thomas · CIK 0001713357 · SVP, China & APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,454 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 20% on February 19, 2022, 20% on February 19, 2023, and 60% on February 19, 2024, subject to continued service through each vesting date. F2 · balance_after: Since the date of the Reporting Person's last ownership report, he transferred 5,048 shares in a transfer exempt from Section 16. Read SEC document |
| February 19, 2021 Filed Feb 24, 2021 01:41 UTC |
Wang Henry CEVP, General Counsel
|
GrantCommon Stock | 4,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013536 · doc4.xml · nonDerivative · entry 1 Wang Henry C · CIK 0001738879 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,615 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 20% on February 19, 2022, 20% on February 19, 2023, and 60% on February 19, 2024, subject to continued service through each vesting date. Read SEC document |
| February 19, 2021 Filed Feb 24, 2021 01:40 UTC |
LEVY ROBERTEVP, WW Affairs & Latin Am.
|
GrantCommon Stock | 3,362 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013535 · doc4.xml · nonDerivative · entry 1 LEVY ROBERT · CIK 0001311283 · EVP, WW Affairs & Latin Am. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 532,470 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 20% on February 19, 2022, 20% on February 19, 2023, and 60% on February 19, 2024, subject to continued service through each vesting date. Read SEC document |
| February 19, 2021 Filed Feb 24, 2021 01:37 UTC |
Amezquita AlexanderChief Financial Officer
|
GrantCommon Stock | 2,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013531 · doc4.xml · nonDerivative · entry 1 Amezquita Alexander · CIK 0001721325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,821 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 20% on February 19, 2022, 20% on February 19, 2023, and 60% on February 19, 2024, subject to continued service through each vesting date. Read SEC document |
| February 19, 2021 Filed Feb 24, 2021 01:39 UTC |
Hoffman Alan LEVP, Global Corporate Affairs
|
GrantCommon Stock | 5,172 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013533 · doc4.xml · nonDerivative · entry 1 Hoffman Alan L · CIK 0001624527 · EVP, Global Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,833 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 20% on February 19, 2022, 20% on February 19, 2023, and 60% on February 19, 2024, subject to continued service through each vesting date. Read SEC document |
| February 19, 2021 Filed Feb 24, 2021 01:36 UTC |
PEZZULLO DAVIDChief Operating Officer
|
GrantCommon Stock | 7,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013529 · doc4.xml · nonDerivative · entry 1 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,702 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 20% on February 19, 2022, 20% on February 19, 2023, and 60% on February 19, 2024, subject to continued service through each vesting date. Read SEC document |
| February 19, 2021 Filed Feb 24, 2021 01:35 UTC |
DeSimone JohnPresident
|
GrantCommon Stock | 11,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013527 · doc4.xml · nonDerivative · entry 1 DeSimone John · CIK 0001463405 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,256 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 20% on February 19, 2022, 20% on February 19, 2023, and 60% on February 19, 2024, subject to continued service through each vesting date. Read SEC document |
| February 19, 2021 Filed Feb 24, 2021 01:34 UTC |
Agwunobi John ODirector · Chairman and CEO
|
GrantCommon Stock | 23,277 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013526 · doc4.xml · nonDerivative · entry 1 Agwunobi John O · CIK 0001627893 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,987 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 20% on February 19, 2022, 20% on February 19, 2023, and 60% on February 19, 2024, subject to continued service through each vesting date. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 01:07 UTC |
LEVY ROBERTEVP, WW Affairs & Latin Am.
|
SaleCommon Stock | 11,128 | $55.46 | $617,165.56 |
DisclosureSEC source: 0001209191-21-011040 · doc4.xml · nonDerivative · entry 3 LEVY ROBERT · CIK 0001311283 · EVP, WW Affairs & Latin Am. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 529,108 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $55.12 to $55.74. The price reported reflects the weighted average sale price of $55.4606. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 01:07 UTC |
LEVY ROBERTEVP, WW Affairs & Latin Am.
|
Exercise / conversionStock Appreciation Rights · Derivative | 41,666 | $0.00 Strike: $26.65 | $0.00 |
DisclosureSEC source: 0001209191-21-011040 · doc4.xml · derivative · entry 4 LEVY ROBERT · CIK 0001311283 · EVP, WW Affairs & Latin Am. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41,666 shares Expires 2021-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The stock appreciation rights ("SARs") were previously reported as covering 20,833 shares at an exercise price of $53.29 per share. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · shares: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The stock appreciation rights ("SARs") were previously reported as covering 20,833 shares at an exercise price of $53.29 per share. F4 · derivative.exercise_date: The SARS were granted on May 18, 2011. 20% vested on May 18, 2012, 20% vested on May 18, 2013 and the remaining 60% vested on May 18, 2014. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 01:07 UTC |
LEVY ROBERTEVP, WW Affairs & Latin Am.
|
Tax withholdingCommon Stock | 30,538 | $56.66 | $1,730,283.08 |
DisclosureSEC source: 0001209191-21-011040 · doc4.xml · nonDerivative · entry 2 LEVY ROBERT · CIK 0001311283 · EVP, WW Affairs & Latin Am. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540,236 Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 01:07 UTC |
LEVY ROBERTEVP, WW Affairs & Latin Am.
|
Exercise / conversionCommon Stock | 41,666 | $26.65 | $1,110,190.57 |
DisclosureSEC source: 0001209191-21-011040 · doc4.xml · nonDerivative · entry 1 LEVY ROBERT · CIK 0001311283 · EVP, WW Affairs & Latin Am. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 570,774 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 01:31 UTC |
DeSimone JohnPresident
|
SaleCommon Stock | 6,180 | $59.00 | $364,620.00 |
DisclosureSEC source: 0001209191-21-009472 · doc4.xml · nonDerivative · entry 5 DeSimone John · CIK 0001463405 · President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 66,805 F3 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Trust. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 01:29 UTC |
PEZZULLO DAVIDChief Operating Officer
|
SaleCommon Stock | 13,238 | $58.35 | $772,490.25 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 15 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,943 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · price: This transaction was executed in multiple trades at prices ranging from $58.0000 to $58.6250. The price reported reflects the weighted average sale price of $58.3540. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 01:29 UTC |
PEZZULLO DAVIDChief Operating Officer
|
SaleCommon Stock | 15,801 | $57.61 | $910,357.23 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 14 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,181 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: This transaction was executed in multiple trades at prices ranging from $57.0900 to $57.9900. The price reported reflects the weighted average sale price of $57.6139. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 01:29 UTC |
PEZZULLO DAVIDChief Operating Officer
|
SaleCommon Stock | 5,644 | $56.73 | $320,162.67 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 13 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,982 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $56.2100 to $56.9900. The price reported reflects the weighted average sale price of $56.7262. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 01:31 UTC |
DeSimone JohnPresident
|
SaleCommon Stock | 65,416 | $56.00 | $3,663,335.25 |
DisclosureSEC source: 0001209191-21-009472 · doc4.xml · nonDerivative · entry 4 DeSimone John · CIK 0001463405 · President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 72,985 F3 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Trust. F4 · price: This transaction was executed in multiple trades at prices ranging from $56.00 to $56.005. The price reported reflects the weighted average sale price of $56.0006. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:44 UTC |
LEVY ROBERTEVP, WW Affairs & Latin Am.
|
Tax withholdingCommon Stock | 6,966 | $55.83 | $388,911.78 |
DisclosureSEC source: 0001209191-21-009480 · doc4.xml · nonDerivative · entry 2 LEVY ROBERT · CIK 0001311283 · EVP, WW Affairs & Latin Am. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 529,108 F2 · shares: Units withheld to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:44 UTC |
LEVY ROBERTEVP, WW Affairs & Latin Am.
|
GrantCommon Stock | 19,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-009480 · doc4.xml · nonDerivative · entry 1 LEVY ROBERT · CIK 0001311283 · EVP, WW Affairs & Latin Am. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536,074 F1 · shares: Represents common shares earned by the Reporting Person in connection with the vesting of performance share units ("PSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan based on pre-established performance goals for a 2018-2020 performance period. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:46 UTC |
Hoffman Alan LEVP, Global Corporate Affairs
|
Tax withholdingCommon Stock | 6,955 | $55.83 | $388,297.65 |
DisclosureSEC source: 0001209191-21-009482 · doc4.xml · nonDerivative · entry 2 Hoffman Alan L · CIK 0001624527 · EVP, Global Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,661 F2 · shares: Units withheld to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:46 UTC |
Hoffman Alan LEVP, Global Corporate Affairs
|
GrantCommon Stock | 19,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-009482 · doc4.xml · nonDerivative · entry 1 Hoffman Alan L · CIK 0001624527 · EVP, Global Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,616 F1 · shares: Represents common shares earned by the Reporting Person in connection with the vesting of performance share units ("PSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan based on pre-established performance goals for a 2018-2020 performance period. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:42 UTC |
Wang Henry CEVP, General Counsel
|
Tax withholdingCommon Stock | 6,966 | $55.83 | $388,911.78 |
DisclosureSEC source: 0001209191-21-009478 · doc4.xml · nonDerivative · entry 2 Wang Henry C · CIK 0001738879 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,477 F2 · shares: Units withheld to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:42 UTC |
Wang Henry CEVP, General Counsel
|
GrantCommon Stock | 19,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-009478 · doc4.xml · nonDerivative · entry 1 Wang Henry C · CIK 0001738879 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,443 F1 · shares: Represents common shares earned by the Reporting Person in connection with the vesting of performance share units ("PSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan based on pre-established performance goals for a 2018-2020 performance period. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:40 UTC |
Agwunobi John ODirector · Chairman and CEO
|
Tax withholdingCommon Stock | 17,110 | $55.83 | $955,251.30 |
DisclosureSEC source: 0001209191-21-009476 · doc4.xml · nonDerivative · entry 2 Agwunobi John O · CIK 0001627893 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,710 F3 · shares: Units withheld to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:40 UTC |
Agwunobi John ODirector · Chairman and CEO
|
GrantCommon Stock | 38,018 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-009476 · doc4.xml · nonDerivative · entry 1 Agwunobi John O · CIK 0001627893 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,820 F1 · shares: Represents common shares earned by the Reporting Person in connection with the vesting of performance share units ("PSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan based on pre-established performance goals for a 2018-2020 performance period. F2 · balance_after: Balance reflects shares purchased through the Issuer's Herbalife Ltd. Employee Stock Purchase Plan since last reported on Form 4. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:31 UTC |
DeSimone JohnPresident
|
SaleCommon Stock | 7,569 | $56.00 | $423,864.00 |
DisclosureSEC source: 0001209191-21-009472 · doc4.xml · nonDerivative · entry 3 DeSimone John · CIK 0001463405 · President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 138,401 F3 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Trust. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:31 UTC |
DeSimone JohnPresident
|
Tax withholdingCommon Stock | 16,226 | $55.83 | $905,897.58 |
DisclosureSEC source: 0001209191-21-009472 · doc4.xml · nonDerivative · entry 2 DeSimone John · CIK 0001463405 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,618 F2 · shares: Units withheld to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:31 UTC |
DeSimone JohnPresident
|
GrantCommon Stock | 38,018 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-009472 · doc4.xml · nonDerivative · entry 1 DeSimone John · CIK 0001463405 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,844 F1 · shares: Represents common shares earned by the Reporting Person in connection with the vesting of performance share units ("PSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan based on pre-established performance goals for a 2018-2020 performance period. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Exercise / conversionStock Appreciation Rights · Derivative | 45,902 | $0.00 Strike: $28.60 | $0.00 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · derivative · entry 20 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,902 shares Expires 2027-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F15 · derivative.exercise_price: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 22,951 shares at an exercise price of $57.19 per share. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F15 · shares: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 22,951 shares at an exercise price of $57.19 per share. F16 · derivative.exercise_date: The SARS were granted on February 27, 2017. 20% vested on February 27, 2018, 20% vested on February 27, 2019 and the remaining 60% vested on February 27, 2020. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Exercise / conversionStock Appreciation Rights · Derivative | 43,668 | $0.00 Strike: $31.26 | $0.00 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · derivative · entry 19 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 43,668 shares Expires 2026-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_price: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 21,834 shares at an exercise price of $62.51 per share. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F13 · shares: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 21,834 shares at an exercise price of $62.51 per share. F14 · derivative.exercise_date: The SARS were granted on May 9, 2016. 20% vested on May 9, 2017, 20% vested on May 9, 2018 and the remaining 60% vested on May 9, 2019. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Exercise / conversionStock Appreciation Rights · Derivative | 29,508 | $0.00 Strike: $39.79 | $0.00 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · derivative · entry 18 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,508 shares Expires 2023-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 14,754 shares at an exercise price of $79.58 per share. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F11 · shares: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 14,754 shares at an exercise price of $79.58 per share. F12 · derivative.exercise_date: The SARS were granted on December 19, 2013. 20% vested on June 21, 2014, 20% vested on June 21, 2015 and the remaining 60% vested on June 21, 2016. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Exercise / conversionStock Appreciation Rights · Derivative | 6,816 | $0.00 Strike: $33.85 | $0.00 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · derivative · entry 17 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,816 shares Expires 2022-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 3,408 shares at an exercise price of $67.70 per share. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F9 · shares: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 3,408 shares at an exercise price of $67.70 per share. F10 · derivative.exercise_date: The SARS were granted on March 1, 2012. 20% vested on March 1, 2013, 20% vested on March 1, 2014 and the remaining 60% vested on March 1, 2015. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Exercise / conversionStock Appreciation Rights · Derivative | 20,764 | $0.00 Strike: $26.65 | $0.00 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · derivative · entry 16 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,764 shares Expires 2021-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The stock appreciation rights ("SARs") were previously reported as covering 10,382 shares at an exercise price of $53.29 per share. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7 · shares: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The stock appreciation rights ("SARs") were previously reported as covering 10,382 shares at an exercise price of $53.29 per share. F8 · derivative.exercise_date: The SARS were granted on May 18, 2011. 20% vested on May 18, 2012, 20% vested on May 18, 2013 and the remaining 60% vested on May 18, 2014. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Tax withholdingCommon Stock | 17,672 | $55.83 | $986,627.76 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 12 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,626 F3 · shares: Units withheld to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC |
PEZZULLO DAVIDChief Operating Officer
|
GrantCommon Stock | 35,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 11 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,298 F2 · shares: Represents common shares earned by the Reporting Person in connection with the vesting of performance share units ("PSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan based on pre-established performance goals for a 2018-2020 performance period. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Tax withholdingCommon Stock | 34,614 | $55.83 | $1,932,499.62 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 10 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,656 Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Exercise / conversionCommon Stock | 45,902 | $28.60 | $1,312,567.69 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 9 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,270 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Tax withholdingCommon Stock | 33,978 | $55.83 | $1,896,991.74 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 8 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,368 Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Exercise / conversionCommon Stock | 43,668 | $31.26 | $1,364,843.34 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 7 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Tax withholdingCommon Stock | 24,579 | $55.83 | $1,372,245.57 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 6 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,678 Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Exercise / conversionCommon Stock | 29,508 | $39.79 | $1,174,123.32 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 5 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,257 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Tax withholdingCommon Stock | 5,061 | $55.83 | $282,555.63 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 4 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,749 Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Exercise / conversionCommon Stock | 6,816 | $33.85 | $230,721.60 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 3 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.